Evidence map›Paper›PMID 28720455›Full record

ArticlePapillomavirus research (Amsterdam, Netherlands)2017

Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice.

Brandon Brown, Magi Ishak Gabra, Harry Pellman

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Papillomavirus research (Amsterdam, Netherlands), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03510091 (Video-assisted Counseling for Human Papillomavirus Vaccination), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03510091 nacompletednot on this mapstarted 2018, after this paper: background citation

Video-assisted Counseling for Human Papillomavirus Vaccination: A Pilot Study

TypeinterventionalSponsorLe Bonheur Children's HospitalRan2018 to 2019Enrolled21ConditionsHuman Papillomavirus InfectionArmsCounseling
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Knowledge, Attitudes, and Behaviors Regarding HPV Vaccination and Self-Sampling Among US Young Adults.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Brandon BrownCenter for Healthy Communities, School of Medicine, University of California, 900 University Avenue, Riverside, CA 92521, USA. Electronic address: brandon.brown@medsch.ucr.edu.
Magi Ishak GabraSchool of Medicine, University of California, 900 University Avenue, Riverside, CA 92521, USA.
Harry PellmanUniversity of California, Irvine, Edinger Medical Group, 9900 Talbert, Suite 201, Fountain Valley, CA 92708, USA.
University of California, Riverside · USUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the effectiveness and availability of the Human Papillomavirus (HPV) vaccine, HPV remains the most common sexually transmitted infection in the United States and has the lowest initiation rate of any routinely recommended teen vaccine. In January 2015, we surveyed parents at a Southern California pediatric private practice about reasons they accept or refuse HPV vaccine for their children. Of the 200 consecutive parents that had HPV vaccine initiation recommended for their child, 123 (61.5%) children were male and 38.5% were female. The overall age range of children was 10-17 years (median 12 years). Of the 164 (82.0%) who accepted the vaccine, a higher percentage were male (88.6% vs 71.4%, p=0.001). The most common reasons for accepting was strength of provider recommendation (84.1%) and available information (63.4%). The most common (52.8%) reason for refusing was wanting to learn more about the vaccine. These results further support the importance of both the strength of physician recommendation and improving public education about the vaccine.

Indexed as

AcceptabilityHPVHPV VaccinePhysician Recommendation

Identifiers

PMID28720455
PMCPMC5883214
OpenAlexW2572385469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.